- Home
- AACT vs ARCT Comparison
AACT vs ARCT Comparison
Compare AACT & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AACT
- ARCT
- Stock Information
- Founded
- AACT 2021
- ARCT 2013
- Country
- AACT United States
- ARCT United States
- Employees
- AACT N/A
- ARCT N/A
- Industry
- AACT
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- AACT
- ARCT Health Care
- Exchange
- AACT Nasdaq
- ARCT Nasdaq
- Market Cap
- AACT 677.5M
- ARCT 602.7M
- IPO Year
- AACT 2023
- ARCT N/A
- Fundamental
- Price
- AACT $10.91
- ARCT $17.07
- Analyst Decision
- AACT
- ARCT Strong Buy
- Analyst Count
- AACT 0
- ARCT 7
- Target Price
- AACT N/A
- ARCT $65.00
- AVG Volume (30 Days)
- AACT 240.5K
- ARCT 454.1K
- Earning Date
- AACT 01-01-0001
- ARCT 11-07-2024
- Dividend Yield
- AACT N/A
- ARCT N/A
- EPS Growth
- AACT 48.19
- ARCT N/A
- EPS
- AACT 0.43
- ARCT N/A
- Revenue
- AACT N/A
- ARCT $160,399,000.00
- Revenue This Year
- AACT N/A
- ARCT $13.02
- Revenue Next Year
- AACT N/A
- ARCT $5.58
- P/E Ratio
- AACT $25.33
- ARCT N/A
- Revenue Growth
- AACT N/A
- ARCT N/A
- 52 Week Low
- AACT $10.35
- ARCT $14.93
- 52 Week High
- AACT $11.00
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- AACT 60.62
- ARCT 42.22
- Support Level
- AACT $10.89
- ARCT $14.93
- Resistance Level
- AACT $10.95
- ARCT $18.09
- Average True Range (ATR)
- AACT 0.02
- ARCT 1.47
- MACD
- AACT 0.00
- ARCT -0.13
- Stochastic Oscillator
- AACT 57.89
- ARCT 32.04
About AACT Ares Acquisition Corporation II
Ares Acquisition Corp II is a blank check company.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.